We are live on
!
Find out more
FC
Finepoint Capital Portfolio holdings
AUM
$1.95B
1-Year Est. Return
45.61%
This Fund
S&P 500
This Quarter
Est. Return
-24.74%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$255M
AUM Growth
-$90M
(-26%)
Cap. Flow
-$751K
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
3
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
YPF
YPF
|
+$16.9M |
| 2 |
Cheniere Energy
LNG
|
+$376K |
| 3 |
Manitowoc
MTW
|
+$171K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
+$16M |
| 2 |
Ardelyx
ARDX
|
+$2.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 42% |
| 2 | Financials | 28.05% |
| 3 | Industrials | 23.4% |
| 4 | Real Estate | 6.55% |
| 5 | Healthcare | 0% |
Similar funds
NIM
WPC
SGAM
HA
BC
FFH
NFG
MWA
Finepoint Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Finepoint Capital held 9 positions worth $255M, down 26% from $345M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Finepoint Capital's Q3 2015 filing shows 3 increased and 2 closed positions. The largest sale was Keryx Biopharmaceuticals Inc, an estimated $16M.
By sector, the portfolio is most concentrated in Energy at 42% of assets, down from 43% a quarter earlier, followed by Financials and Industrials.
- Finepoint Capital added most to YPF in Q3 2015, an estimated $16.9M increase.
- Finepoint Capital fully exited Keryx Biopharmaceuticals Inc in Q3 2015, selling an estimated $16M.
- Finepoint Capital's ten largest holdings make up 100% of its $255M portfolio in Q3 2015.
- Finepoint Capital opened 0 new positions and closed 2 in Q3 2015.
- Finepoint Capital's portfolio value fell 26% quarter-over-quarter to $255M.
Based on Finepoint Capital's 13F filing for Q3 2015, filed 13 Nov 2015.